"Survival benefit": The final destination, with still a long way to go

Digestive and Liver Disease

Volumn 42, Issue 9, 2010, Pages 608-610

  Piscaglia, Fabio ^a   Cucchetti, Alessandro ^b   Bolondi, Luigi ^a  

^a Division of Internal Medicine   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT SURVIVAL; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NOTE; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR GROWTH;

EID: 77955263382     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.07.001     Document Type: Note

References (24)

1. Cillo U., Vitale A., Volk M.L., et al. The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis 2010, 42:642-649.
2. Pruett T.L. The allocation of livers for transplantation: a problem of Titanic consideration. Hepatology 2002, 35:960-963.
3. Ringe B., Wittekind C., Bechstein W.O., Bunzendahl H., Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989, 209:88-98.
4. Olthoff K.M., Millis J.M., Rosove M.H., Goldstein L.I., Ramming K.P., Busuttil R.W. Is liver transplantation justified for the treatment of hepatic malignancies?. Arch Surg 1990, 125:1261-1266. discussion 1266-1268.
5. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699.
6. Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD). Hepatology 2007, 45:797-805.
7. Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30:1434-1440.
8. Yao F.Y., Bass N.M., Nikolai B., et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003, 9:684-692.
9. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470.
10. Gitto S., Lorenzini S., Biselli M., Conti F., Andreone P., Bernardi M. Allocation priority in non-urgent liver transplantation: an overview of proposed scoring systems. Dig Liver Dis 2009, 41:700-706.
11. Angelico M., Gridelli B., Strazzabosco M. Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A. I. S. F.). Dig Liver Dis 2005, 37:461-467.
12. Merion R.M., Schaubel D.E., Dykstra D.M., Freeman R.B., Port F.K., Wolfe R.A. The survival benefit of liver transplantation. Am J Transplant 2005, 5:307-313.
13. Schaubel D.E., Guidinger M.K., Biggins S.W., et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009, 9:970-981.
14. Pelletier S.J., Schaubel D.E., Wei G., et al. Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl 2007, 13:1678-1683.
15. Schaubel D.E., Sima C.S., Goodrich N.P., Feng S., Merion R.M. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008, 8:419-425.
16. De Giorgio M., Vezzoli S., Cohen E., et al. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl 2010, 16:503-512.
17. Cillo U., Vitale A., Grigoletto F., et al. Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant 2007, 7:972-981.
18. Freeman R.B., Edwards E.B., Harper A.M. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006, 6:1416-1421.
19. Piscaglia F., Camaggi V., Ravaioli M., et al. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transpl 2007, 13:857-866.
20. Mazzaferro V., Llovet J.M., Miceli R., et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009, 10:35-43.
21. Barber K., Blackwell J., Collett D., Neuberger J. Life expectancy of adult liver allograft recipients in the UK. Gut 2007, 56:279-282.
22. Hoshida Y., Villanueva A., Llovet J.M. Molecular profiling to predict hepatocellular carcinoma outcome. Expert Rev Gastroenterol Hepatol 2009, 3:101-103.
23. Heading 3.6.4.4, accessed 10 July 2010. http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_8.pdf.
24. Pomfret E.A., Washburn K., Wald C., et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010, 16:262-278.